Given we’re headquartered in the BioCT Commons, we can’t help but notice the buzz and excitement around biopharma innovation in our home state. Forty to fifty new biotech ventures have emerged in the New Haven area in the past 10 years.
According to Yale’s Office of Cooperative Research (OCR), New Haven startups, based on Yale intellectual property, have raised more than $1 billion in venture capital funding and $11 billion in public markets in 2018. Entrepreneurs are creating new companies at such a rapid clip that laboratory bench space is difficult to find throughout the state.
We’re excited to assist both new and established companies with proven biopharma marketing.